William J Febbo
CIK 1413987 · CEO · last filed 2026-06-26
William J Febbo is a CEO who has filed 67 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for MYO, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$11.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $25.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OPRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
236 FIFTH AVENUE, SUITE 400
NEW YORK, NY 10001
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MYO | Director | 123,704 | $1.20 | $148.4K | $0 | 2 | 2026-06-26 |
| OPRX | CEO | 600,852 | $9.07 | $5.45M | -$11.56M | 32 | 2025-02-20 |
| Augmedix, Inc. (AUGX) Delisted | Director | 162,583 | $2.35 | $382.1K | $59.7K | 6 | 2024-07-15 |
| MODD | Director | 3,054 | $1.65 | $5.0K | $0 | 8 | 2023-07-05 |
| LFMDP | Director | 450,000 | $21.60 | $9.72M | $0 | 1 | 2023-06-22 |
| Merriman Holdings, Inc (MERR) Delisted | Director | — | — | — | $0 | 1 | 2008-05-06 |
| MEM | Director | 259,271 | $39.06 | $10.13M | $15.0K | 1 | 2007-11-26 |
Recent Filings
67 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | MYO | Grant (A) | +78,704 | $0 | EDGAR |
| 2026-04-16 | MYO | Grant (A) | +45,000 | $0 | EDGAR |
| 2025-02-20 | OPRX | Tax (F) | −401 | -$2.7K | EDGAR |
| 2024-12-16 | OPRX | Buy (P) | +20,000 | $100.2K | EDGAR |
| 2024-10-04 | — | Disp (D) | −162,583 | -$382.1K | |
| 2024-07-15 | Augmedix, Inc. (AUGX) Delisted | Exer (M) | +21,598 | $0 | EDGAR |
| 2024-06-12 | OPRX | Mixed | +28,113 | -$7.3K | EDGAR |
| 2024-04-24 | OPRX | Grant (A) | +15,000 | $0 | EDGAR |
| 2024-04-17 | OPRX | Grant (A) | +60,000 | $0 | EDGAR |
| 2024-01-18 | OPRX | Mixed | +6,744 | -$38.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.